Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE). - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Hematology/Oncology Clinics of North America Année : 2014

Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE).

Résumé

The management and understanding of hereditary hemochromatosis have evolved with recent advances in iron biology and the associated discovery of numerous genes involved in iron metabolism. HFE-related (type 1) hemochromatosis remains the most frequent form, characterized by C282Y mutation homozygosity. Rare forms of hereditary hemochromatosis include type 2 (A and B, juvenile hemochromatosis caused by HJV and HAMP mutation), type 3 (related to TFR2 mutation), and type 4 (A and B, ferroportin disease). The diagnostic evaluation relies on comprehension of the involved pathophysiologic defect, and careful characterization of the phenotype, which gives clues to guide appropriate genetic testing.
Fichier non déposé

Dates et versions

hal-01134766 , version 1 (24-03-2015)

Identifiants

Citer

Edouard Bardou-Jacquet, Pierre Brissot. Diagnostic evaluation of hereditary hemochromatosis (HFE and non-HFE).. Hematology/Oncology Clinics of North America, 2014, 28 (4), pp.625-35, v. ⟨10.1016/j.hoc.2014.04.006⟩. ⟨hal-01134766⟩
39 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More